| P50 | author | Asunción López-Calderón | Q46087110 |
| | Ana Isabel Martín | Q46087074 |
| P2093 | author name string | Estíbaliz Castillero | |
| | María López-Menduiña | |
| | María Angeles Villanúa | |
| P2860 | cites work | Activity-unrelated neural control of myogenic factors in a slow muscle | Q46318198 |
| | Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors | Q46414798 |
| | Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis | Q46677464 |
| | Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. | Q47582973 |
| | Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation | Q48281187 |
| | Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure. | Q48386276 |
| | Differential skeletal muscle gene expression after upper or lower motor neuron transection. | Q51823753 |
| | IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. | Q54741209 |
| | Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green | Q24801355 |
| | Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis | Q24805238 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3 | Q28360561 |
| | Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice | Q28512324 |
| | Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression | Q28565720 |
| | Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei | Q28576625 |
| | Identification of ubiquitin ligases required for skeletal muscle atrophy | Q28582211 |
| | Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection | Q28582759 |
| | Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli | Q33332170 |
| | The ubiquitin system, disease, and drug discovery | Q33384295 |
| | Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation | Q34150320 |
| | Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice. | Q35750099 |
| | Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice | Q36007403 |
| | Normal growth and development in the absence of hepatic insulin-like growth factor I | Q36394699 |
| | Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6) | Q36720307 |
| | Regulation of muscle mass by growth hormone and IGF-I. | Q36736100 |
| | Local insulin-like growth factor I prevents sepsis-induced muscle atrophy | Q37381871 |
| | Role of IGF-I in skeletal muscle mass maintenance | Q37591648 |
| | Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. | Q37704568 |
| | IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo | Q38355427 |
| | Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility | Q39840728 |
| | IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 |
| | Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting | Q40891663 |
| | Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury | Q43104075 |
| | Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors | Q43278882 |
| | Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis | Q43770839 |
| | Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol | Q43819489 |
| | Insulin-like growth factor-I inhibits lysosomal and proteasome-dependent proteolysis in skeletal muscle after burn injury | Q44156622 |
| | Skeletal Muscle wasting and contractile performance in septic rats. | Q44710970 |
| | Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes | Q45000394 |
| P433 | issue | 2 | |
| P304 | page(s) | R541-51 | |
| P577 | publication date | 2010-06-02 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3. | |
| P478 | volume | 299 | |